FDA.reportPublic FDA data

influenza virus vaccine 2026 high dose (trivalent - Singapore/Switzerland/Michigan) 0.5 mL Prefilled Syringe

RxCUI
2738154
RxNorm name
influenza virus vaccine 2026 high dose (trivalent - Singapore/Switzerland/Michigan) 0.5 mL Prefilled Syringe
Display name
influenza virus vaccine 2026 high dose (trivalent - Singapore/Switzerland/Michigan) 0.5 mL Prefilled Syringe
Full name
influenza virus vaccine 2026 high dose (trivalent - Singapore/Switzerland/Michigan) 0.5 mL Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103914Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone QuadrivalentInfluenza Virus Vaccine351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
96ca1b4c-67bf-3db6-24c5-c4841b073c66influenza virus vaccine 2026 high dose (trivalent - Singapore/Switzerland/Michigan) 0.5 mL Prefilled SyringeSY14These highlights do not include all the information needed to use Fluzone ® High-Dose Southern Hemisphere safely and effectively. See full prescribing information for Fluzone High-Dose Southern Hemisphere. Fluzone High-Dose Southern Hemisphere (Influenza Vaccine) injectable suspension, for intramuscular use 2026 Formula Initial U.S. Approval: 200920260430
96ca1b4c-67bf-3db6-24c5-c4841b073c66influenza virus vaccine 2026 high dose (trivalent - Singapore/Switzerland/Michigan) 0.5 mL Prefilled SyringePSN14These highlights do not include all the information needed to use Fluzone ® High-Dose Southern Hemisphere safely and effectively. See full prescribing information for Fluzone High-Dose Southern Hemisphere. Fluzone High-Dose Southern Hemisphere (Influenza Vaccine) injectable suspension, for intramuscular use 2026 Formula Initial U.S. Approval: 200920260430
96ca1b4c-67bf-3db6-24c5-c4841b073c660.5 ML influenza A virus A/Singapore/GP20238/2024 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.12 MG/ML Prefilled SyringeSCD14These highlights do not include all the information needed to use Fluzone ® High-Dose Southern Hemisphere safely and effectively. See full prescribing information for Fluzone High-Dose Southern Hemisphere. Fluzone High-Dose Southern Hemisphere (Influenza Vaccine) injectable suspension, for intramuscular use 2026 Formula Initial U.S. Approval: 200920260430